Vellenga E - Search Results

1

Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation.

Sontakke P, Koczula KM, Jaques J, Wierenga AT, Brouwers-Vos AZ, Pruis M, Günther UL, Vellenga E, Schuringa JJ. Sontakke P, et al. Among authors: vellenga e. PLoS One. 2016 Apr 7;11(4):e0153226. doi: 10.1371/journal.pone.0153226. eCollection 2016. PLoS One. 2016. PMID: 27055152 Free PMC article.

2

Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels.

Wierenga AT, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. Mol Cell Biol. 2008 Nov;28(21):6668-80. doi: 10.1128/MCB.01025-08. Epub 2008 Sep 8. Mol Cell Biol. 2008. PMID: 18779318 Free PMC article.

3

Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.

Han L, Wierenga AT, Rozenveld-Geugien M, van de Lande K, Vellenga E, Schuringa JJ. Han L, et al. Among authors: vellenga e. PLoS One. 2009 Nov 24;4(11):e7989. doi: 10.1371/journal.pone.0007989. PLoS One. 2009. PMID: 19956772 Free PMC article.

4

Convergence of hypoxia and TGFβ pathways on cell cycle regulation in human hematopoietic stem/progenitor cells.

Wierenga AT, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. PLoS One. 2014 Mar 31;9(3):e93494. doi: 10.1371/journal.pone.0093494. eCollection 2014. PLoS One. 2014. PMID: 24686421 Free PMC article.

5

ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.

Capala ME, Vellenga E, Schuringa JJ. Capala ME, et al. Among authors: vellenga e. PLoS One. 2014 Oct 31;9(10):e111568. doi: 10.1371/journal.pone.0111568. eCollection 2014. PLoS One. 2014. PMID: 25360637 Free PMC article.

6

Depletion of SAM50 Specifically Targets BCR-ABL-Expressing Leukemic Stem and Progenitor Cells by Interfering with Mitochondrial Functions.

Capala ME, Pruis M, Vellenga E, Schuringa JJ. Capala ME, et al. Among authors: vellenga e. Stem Cells Dev. 2016 Mar 1;25(5):427-37. doi: 10.1089/scd.2015.0151. Epub 2016 Feb 8. Stem Cells Dev. 2016. PMID: 26855047

7

BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.

Carretta M, Brouwers-Vos AZ, Bosman M, Horton SJ, Martens JHA, Vellenga E, Schuringa JJ. Carretta M, et al. Among authors: vellenga e. PLoS One. 2017 Dec 14;12(12):e0189102. doi: 10.1371/journal.pone.0189102. eCollection 2017. PLoS One. 2017. PMID: 29240787 Free PMC article.

8

Proteolytic degradation of Smad4 in extracts of AML blasts.

Wierenga AT, Eggen BJ, Kruijer W, Vellenga E. Wierenga AT, et al. Among authors: vellenga e. Leuk Res. 2002 Dec;26(12):1105-11. doi: 10.1016/s0145-2126(02)00054-1. Leuk Res. 2002. PMID: 12443883

9

STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.

Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. Blood. 2006 Jun 1;107(11):4326-33. doi: 10.1182/blood-2005-11-4608. Epub 2006 Feb 2. Blood. 2006. PMID: 16455947 Free article.

10

Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.

Schepers H, Wierenga AT, van Gosliga D, Eggen BJ, Vellenga E, Schuringa JJ. Schepers H, et al. Among authors: vellenga e. Blood. 2007 Aug 15;110(4):1317-25. doi: 10.1182/blood-2006-10-052175. Epub 2007 May 2. Blood. 2007. PMID: 17475913 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters